Elsevier

Biochemical Pharmacology

Volume 46, Issue 9, 2 November 1993, Pages 1591-1600
Biochemical Pharmacology

Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers model

https://doi.org/10.1016/0006-2952(93)90328-TGet rights and content

Abstract

The transport of a new bisphosphonate, Tiludronate, was investigated on the human adenocarcinoma cell line, CACO-2. Experiments were performed 7–16 days after cells achieved confluence, conditions under which they form well-differentiated monolayers joined by tight junctions. Tiludronate transport rate across CACO-2 monolayers was independent of the temperature (4° versus 37°), of the polarity of the cell membrane (apical-to-basolateral versus basolateral-to-apical), and of the presence of metabolic poisons (sodium azide). Its transport was enhanced by either the presence of EGTA in the incubation buffer, i.e. when extracellular Ca2+ concentration was reduced, or by the pretreatment of monolayers with EGTA, i.e. when the intercellular spaces and the tight junctions were widened. Based on these different observations, we could suggest that Tiludronate mainly used the paracellular pathway to cross the intestinal epithelium. An increase in the Tiludronate permeability coefficient was also observed following treatment of cells with high Tiludronate concentrations, as a consequence of the direct effect of this compound on the extracellular Ca2+ ions. Hence, for high drug concentrations, i.e. 20 mM, we observed a decrease in free extracellular Ca2+ concentration, an increase in the transepithelial electrical resistance and an increase in the transport of [14C]polyethyleneglycol ([14C]PEG400), a probe for the paracellular pathway. The results indicate that Tiludronate is transported across CACO-2 monolayers by the paracellular route. Moreover, it can affect its own transport by its concentration-dependent effect on tight junction widening.

References (44)

  • A Baranczyk-Kuzma et al.

    Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco- 2 cells

    Life Sci

    (1991)
  • HB Pollard et al.

    Application of Bradford's protein assay to adrenal gland subcellular fractions

    Anal Biochem

    (1978)
  • M Messer et al.

    A one step ultra-micromethod for the assay of intestinal dissacharidases

    Anal Biochem

    (1966)
  • A Garen et al.

    A fine structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterisation of alkaline phospha

    Biochim Biophys Acta

    (1960)
  • P Artursson

    Cell culture as model for drug absorption across the intestinal mucosa

    Crit Rev Ther Drug Carrier System

    (1991)
  • M Pinto et al.

    Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture

    Biol Cell

    (1983)
  • A Zweibaum

    Differentiation of human colon cancer cells

    Life Sci

    (1991)
  • G Wilson

    Growth and characterization of cell and tissue cultures for the study of drug transport

    Life Sci

    (1991)
  • RT Borchardt et al.

    Pharmaceutical applications of cell culture: an overview

    Life Sci

    (1991)
  • IJ Hidalgo et al.

    Amino acid transport in a novel model system of the intestinal epithelium (Caco-2) (abstract)

    Pharm Res

    (1988)
  • MH Hu et al.

    Effect of pH and glucose on l-phenylalanine transport across an intestinal epithelial cell model system (Caco-2) (abstract)

    Pharm Res

    (1989)
  • M Hu et al.

    Mechanism of l-α- methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)

    Pharm Res

    (1990)
  • Cited by (79)

    • Nanomaterial-mediated photoporation for intracellular delivery

      2023, Acta Biomaterialia
      Citation Excerpt :

      Various biochemical agents including pore-forming agents, chelating agents, and detergents have been explored to permeabilize the cell membrane (Fig. 2c). The category of chelating agents involves ethylene­ diaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), and ethylene glycol tetraacetic acid (EGTA) [53–55]. In the use of chelating agents, the common route is to deplete divalent metal ions such as Ca2+, Mg2+, and Zn2+ which are required for maintaining tight junctions.

    • Methamphetamine enhances caveolar transport of therapeutic agents across the rodent blood-brain barrier

      2022, Cell Reports Medicine
      Citation Excerpt :

      The accumulated EB-Alb was located outside the vasculature (Figures S2C and S2D), indicating that leakage and BBB breakdown had occurred. METH-induced leakage was completely suppressed at 4°C (Figures 1C, S2E, and S2F), demonstrating that it was cold sensitive and thus likely to be dependent on vesicular traffic.20,21 In cultured BBB endothelial cells, METH induces permeability via small pinocytic vesicles with diameters of 70–100 nm, reminiscent of caveolae.17

    • Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer

      2020, Journal of Drug Delivery Science and Technology
    • Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production

      2020, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
    • Alendronate-modified polydopamine-coated paclitaxel nanoparticles for osteosarcoma-targeted therapy

      2019, Journal of Drug Delivery Science and Technology
      Citation Excerpt :

      By specifically attaching to tumor cell recognizing ligands on NPs, the drug can be preferentially endocytosed to achieve effective tumor targeted therapy. Bisphosphonate has long been regarded as an active bone-seeking agent which possesses great affinity to the abundant hydroxyapatite in bone environments [16,17]. Moreover, protein tyrosine phosphatases, which are overexpressed on the osteosarcoma cell surface [18], represent one of the bisphosphonate specific receptors.

    View all citing articles on Scopus
    View full text